businesspress24.com - WorldCare Clinical Appoints Melissa Gebhardt to Lead Business Development and Marketing Strategy
 

WorldCare Clinical Appoints Melissa Gebhardt to Lead Business Development and Marketing Strategy

ID: 1271098

(firmenpresse) - BOSTON, MA -- (Marketwired) -- 10/09/13 -- , a leading imaging CRO focused on maximizing the precision and accuracy of independent assessments in clinical trials, today announced that Melissa Gebhardt has been appointed vice president of business development and marketing.

Gebhardt has more than 20 years of experience in medical sales, marketing and corporate strategy, with a specific focus on clinical trial execution and support. She has worked directly with leading pharmaceutical, biotechnology and medical device sponsors to promote medical image management and analysis, patient recruitment and CRO services for global trials. Gebhardt holds a double bachelor's degree in biology and economics from University of California, Santa Cruz.

"The clinical trials landscape is changing rapidly and Melissa's comprehensive background and extensive experience in multiple facets of clinical research services is a valuable asset for WCC," said Richard Walovitch, PhD, president of WorldCare Clinical, LLC.

"I believe that WCC has a unique value proposition with the primary focus being improving assessments for precision and accuracy," stated Gebhardt. "On-time, on-budget delivery is essential, but the distinct added value is in controlling data variability. We are focused on communicating this message through scientific presentations and publications, videos and our new web site, which explains our approach and expands upon our new service offerings, particularly cardiac and malignancy assessment and adjudication services."

WorldCare Clinical (WCC) is a leading imaging CRO that employs clinical expertise, innovative technology and operational excellence to maximize the precision and accuracy of a blinded independent central review of clinical trial data. Originally founded in 1992 by the Massachusetts General Hospital (MGH) Department of Radiology, WCC has evolved as an independent company while maintaining a strategic relationship with MGH.





For more information, visit our new website at .





For more information, contact:
Bree Bolognese
SVM Public Relations
(760) 298-2353
(401) 490-9700


Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  Peregrine Pharmaceuticals Reports First Quarter Fiscal Year 2014 Financial Results and Recent Developments
ProScan Imaging Group Acquires 100 Percent Ownership of WorldCare Clinical LLC
Bereitgestellt von Benutzer: Marketwired
Datum: 09.10.2013 - 08:00 Uhr
Sprache: Deutsch
News-ID 1271098
Anzahl Zeichen: 0

contact information:
Contact person:
Town:

BOSTON, MA


Phone:

Kategorie:

Trials


Anmerkungen:


Diese Pressemitteilung wurde bisher 294 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"WorldCare Clinical Appoints Melissa Gebhardt to Lead Business Development and Marketing Strategy
"
steht unter der journalistisch-redaktionellen Verantwortung von

WorldCare Clinical (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von WorldCare Clinical



 

Who is online

All members: 10 561
Register today: 0
Register yesterday: 2
Members online: 0
Guests online: 89


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.